scholarly journals Venous Anatomy Influence on the Approach Selection of a Petroclival Clear Cell Meningioma With Associated Multiple Spinal Meningiomas: 2-Dimensional Operative Video

2021 ◽  
Author(s):  
Walid I B N Essayed ◽  
Michael A Mooney ◽  
Ossama Al-Mefty

Abstract Preoperative careful evaluation of the sigmoid transverse sinus and its tributary veins is paramount for the safe surgical planning of petroclival lesions.1,2 When the vein of Labbé is running within the tentorium, classic petrosal approach involving transection of the tentorium is modified to avoid the risk of postoperative morbid temporal lobe venous infarcts.1-3 Thus, the surgical plan should be tailored to the specific patient anatomy as demonstrated in the presented case during which a transmastoid approach was followed, in the same surgical setting, by a middle fossa approach to resect a large petroclival clear cell meningioma with extension into Meckel cave. These meningiomas are WHO grade II tumors with a propensity to local recurrence and cerebrospinal fluid seeding.4 SMARCE1 mutations define this subtype of meningioma, with frequent familial inheritance, and predispose patients to both skull base and spinal clear cell meningiomas.5,6 Maximal surgical resection is the best initial treatment option allowing to withhold or delay the use of radiation in tumors frequently encountered in young patients.7 In this report, we demonstrate the microsurgical techniques deployed to achieve maximal resection of a petroclival clear cell meningioma and associated lumbar and sacral spinal meningiomas in a 20-yr-old patient with a familial SMARCE1 mutation. The patient agreed to the surgical intervention and to the use of her image.

Author(s):  
Philipp Sievers ◽  
◽  
Martin Sill ◽  
Christina Blume ◽  
Arnault Tauziede-Espariat ◽  
...  

AbstractClear cell meningioma represents an uncommon variant of meningioma that typically affects children and young adults. Although an enrichment of loss-of-function mutations in the SMARCE1 gene has been reported for this subtype, comprehensive molecular investigations are lacking. Here we describe a molecularly distinct subset of tumors (n = 31), initially identified through genome-wide DNA methylation screening among a cohort of 3093 meningiomas, of which most were diagnosed histologically as clear cell meningioma. This cohort was further supplemented by an additional 11 histologically diagnosed clear cell meningiomas for analysis (n = 42). Targeted DNA sequencing revealed SMARCE1 mutations in 33/34 analyzed samples, accompanied by a nuclear loss of expression determined via immunohistochemistry and a decreased SMARCE1 transcript expression in the tumor cells. Analysis of time to progression or recurrence of patients within the clear cell meningioma group (n = 14) in comparison to those with meningioma WHO grade 2 (n = 220) revealed a similar outcome and support the assignment of WHO grade 2 to these tumors. Our findings indicate the existence of a highly distinct epigenetic signature of clear cell meningiomas, separate from all other variants of meningiomas, with recurrent mutations in the SMARCE1 gene. This suggests that these tumors may arise from a different precursor cell population than the broad spectrum of the other meningioma subtypes.


Author(s):  
Pranay Soni ◽  
Jianning Shao ◽  
Arbaz Momin ◽  
Diana Lopez ◽  
Lilyana Angelov ◽  
...  

2009 ◽  
Vol 5 (4) ◽  
pp. 324 ◽  
Author(s):  
Prabal Deb ◽  
SubramanyaG.S Datta

2012 ◽  
Vol 28 (12) ◽  
pp. 2143-2151 ◽  
Author(s):  
Zhiqi Li ◽  
Yi Zhang ◽  
Enming Wang ◽  
Zhiqiu Wang ◽  
Wengang Li ◽  
...  

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Kristian Stensland ◽  
Jared Schober ◽  
David Canes ◽  
Navneet Ramesh ◽  
Brendan Waldoch ◽  
...  

2017 ◽  
Vol 24 (3) ◽  
pp. 244
Author(s):  
B. Domingo-Arrué ◽  
R. Gil-Benso ◽  
J. Megías ◽  
L. Navarro ◽  
T. San-Miguel ◽  
...  

We report a case of a recurrent clear cell meningioma (ccm) in the frontal lobe of the brain of a 67-year-old man. The patient developed three recurrences: at 3, 10, and 12 years after his initial surgery. Histopathology observations revealed a grade 2 ccm with positivity for vimentin and epithelial membrane antigen. Expression of E-cadherin was positive only in the primary tumour and in the first available recurrence. Fluorescence in situ hybridization analyses demonstrated 1p and 14q deletions within the last recurrence. Multiplex ligation-dependent probe amplification studies revealed a heterozygous partial NF2 gene deletion, which progressed to total loss in the last recurrence. The last recurrence showed homozygous deletions in CDKN2A and CDKN2B. The RASSF1 gene was hypermethylated during tumour evolution.In this report, we show the genetic alterations of a primary ccm and its recurrences to elucidate their relationships with the changes involved in the progression of this rare neoplasm.


2005 ◽  
Vol 102 (3) ◽  
pp. 303-306 ◽  
Author(s):  
Edward S. Ahn ◽  
Lawrence S. Chin ◽  
Kymberly A. Gyure ◽  
Richard S. Hudes ◽  
John Ragheb ◽  
...  

2018 ◽  
Vol 175 ◽  
pp. 74-83 ◽  
Author(s):  
Jiuhong Li ◽  
Xueyun Deng ◽  
Si Zhang ◽  
Qiguang Wang ◽  
Jian Cheng ◽  
...  

2003 ◽  
Vol 10 (2) ◽  
pp. 264-266 ◽  
Author(s):  
Kayhan KuzeylıÇ ◽  
Ertuğrul Çakir ◽  
Haydar Usul ◽  
Gökalp Karaarslan ◽  
A Kadir Reıs ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document